Potentiation of Scutellarin on Human Tongue Carcinoma Xenograft by Low-Intensity Ultrasound

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Li, Haixia ^a,b   Fan, Haixia ^b   Wang, Zhu ^a   Zheng, Jinhua ^a,b   Cao, Wenwu ^a,c  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; SCUTELLARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CANCER INVASION; CELL SHAPE; CELL VIABILITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW INTENSITY ULTRASOUND THERAPY; MALE; METASTASIS INHIBITION; MIGRATION INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; THERAPY EFFECT; TONGUE CARCINOMA; TUMOR VOLUME; ULTRASOUND THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APIGENIN; APOPTOSIS; CARCINOMA; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GLUCURONATES; HETEROGRAFTS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE OXYGEN SPECIES; SONICATION; SOUND; TONGUE NEOPLASMS; TUMOR BURDEN;

MUS;

EID: 84875449915     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059473     Document Type: Article

References (37)

1. Scully C, Bagan J, (2009) Oral squamous cell carcinoma overview. Oral Oncology 45: 301-308.
2. de Vicente JC, Lequerica-Fernandez P, Santamaria J, Fresno MF, (2007) Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. J Oral Pathol Med 36: 415-424.
3. Kessenbrock K, Plaks V, Werb Z, (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
4. Shah JP, Gil Z (2009) Current concepts in management of oral cancer-surgery. Oral Oncol 45(4-5): p. 394-401.
5. Mazeron R, Tao Y, Lusinchi A, Bourhis J, (2009) Current concepts of management in radiotherapy for head and neck squamous-cell cancer. Oral Oncol 45: 402-408.
6. Specenier PM, Vermorken JB, (2009) Current concepts for the management of head and neck cancer: chemotherapy. Oral Oncol 45: 409-415.
7. DeVita VT, Rosenberg SA, (2012) Two hundred years of cancer research. N Engl J Med 366: 2207-2214.
8. Shibaguchi H, Tsuru H, Kuroki M, (2011) Sonodynamic cancer therapy: a non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer research 31: 2425-2429.
9. Feril L, Tachibana K, Ikeda-Dantsuji Y, Endo H, Harada Y, et al. (2008) Therapeutic potential of low-intensity ultrasound (part 2): biomolecular effects, sonotransfection, and sonopermeabilization. Journal of Medical Ultrasonics 35: 161-167.
10. Li YS, Reid CN, McHale AP, (2008) McHale, Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy. Cancer letters 266: 156-162.
11. Nomikou N, Li YS, McHale AP, (2010) Ultrasound-enhanced drug dispersion through solid tumours and its possible role in aiding ultrasound-targeted cancer chemotherapy. Cancer Letters 288: 94-98.
12. Zolochevska O, Figueiredo ML, (2012) Advances in sonoporation strategies for cancer. Front Biosci (Schol Ed) 4: 988-1006.
13. Yu T, Wang Z, Jiang S, (2001) Potentiation of cytotoxicity of adriamycin on human ovarian carcinoma cell line 3AO by low-level ultrasound. Ultrasonics 39: 307-309.
14. Yu T, Li SL, Zhao JZ, Mason TJ, (2006) Ultrasound: a chemotherapy sensitizer. Technol Cancer Res Treat 5: 51-60.
15. McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS, (2012) Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res 72: 3652-3663.
16. Newman CM, Bettinger T, (2007) Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther 14: 465-475.
17. Shohet RV, Chen S, Zhou YT, Wang Z, Meidell RS, et al. (2000) Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 101: 2554-2556.
18. Zolochevska O, Xia X, Williams BJ, Ramsay A, Li S, et al. (2011) Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo. Hum Gene Ther 22: 1537-1550.
19. Schroeder A, Kost J, Barenholz Y, (2009) Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem Phys Lipids 162: 1-16.
20. Suh SJ, Yoon JW, Lee TK, Jin UH, Kim SL, et al. (2007) Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer. Phytotherapy Research 21: 135-141.
21. Goh D, Lee YH, Ong ES, (2005) Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem 53: 8197-8204.
22. Li H, Huang D, Gao Z, Lv Y, Zhang L, et al. (2010) Scutellarin inhibits cell migration by regulating production of alphavbeta6 integrin and E-cadherin in human tongue cancer cells. Oncol Rep 24: 1153-1160.
23. Gao ZX, Huang DY, Li HX, Zhang LN, Lv YH, et al. (2010) Scutellarin promotes in vitro angiogenesis in human umbilical vein endothelial cells. Biochem Biophys Res Commun 400: 151-156.
24. Song W, Cui H, Zhang R, Zheng J, Cao W, (2011) Apoptosis of SAS cells induced by sonodynamic therapy using 5-aminolevulinic acid sonosensitizer. Anticancer Res 31: 39-45.
25. Teicher BA (2002) Tumor models in cancer research. Totawa, New Jersey: Humana Press. 407-449.
26. Weidner N, Semple JP, Welch WR, Folkman J, (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8.
27. Yu T, Wang Z, Mason TJ, (2004) A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 11: 95-103.
28. Griffin XL, Smith N, Parsons N, Costa ML, (2012) Ultrasound and shockwave therapy for acute fractures in adults. Cochrane Database Syst Rev 2: CD008579.
29. Wang RS, Liu LX, Gu YH, Lin QF, Guo RH, et al. (2010) The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer. Biomed Pharmacother 64: 309-312.
30. Rosenthal I, Sostaric JZ, Riesz P, (2004) Sonodynamic therapy-a review of the synergistic effects of drugs and ultrasound. Ultrasonics sonochemistry 11: 349-363.
31. Huang D, Okada K, Komori C, Itoi E, Suzuki T, (2004) Enhanced antitumor activity of ultrasonic irradiation in the presence of new quinolone antibiotics in vitro. Cancer Science 95: 845-849.
32. Harrison GH, Balcer-Kubiczek EK, Gutierrez PL, (1996) In vitro mechanisms of chemopotentiation by tone-burst ultrasound. Ultrasound in medicine & biology 22: 355-362.
33. Sundaram J, Mellein BR, Mitragotri S, (2003) An experimental and theoretical analysis of ultrasound-induced permeabilization of cell membranes. Biophys J 84: 3087-3101.
34. Koch MO, Gardner T, Cheng L, Fedewa RJ, Seip R, et al. (2007) Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer. J Urol 178: 2366-2370; discussion 2370-2371.
35. Hancock H, Dreher MR, Crawford N, Pollock CB, Shih J, et al. (2009) Evaluation of pulsed high intensity focused ultrasound exposures on metastasis in a murine model. Clin Exp Metastasis 26: 729-738.
36. Oosterhof GO, Cornel EB, Smits GA, Debruyne FM, Schalken JA, (1997) Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol 32: 91-95.
37. Miller DL, Dou C, (2006) The potential for enhancement of mouse melanoma metastasis by diagnostic and high-amplitude ultrasound. Ultrasound Med Biol 32: 1097-1101.